ClinicalTrials.Veeva

Menu

Lower Silesia Sinus Reducer Registry (LSSRR)

R

Regional Cardiology Center, The Copper Health Centre (MCZ),

Status

Enrolling

Conditions

Safety Issues
Efficacy, Self

Treatments

Device: Coronary Sinus Reducer Implantation

Study type

Observational

Funder types

Other

Identifiers

NCT06288165
CopperHealthCentre2

Details and patient eligibility

About

Lower Silesia Sinus Reducer Registry is a , single-center, single-arm registry including patients with chronic disabling refractory angina pectoris (Canadian Cardiovascular Society [CCS] classes 2-4) despite maximally tolerated anti-angina medical therapy who underwent Coronary Sinus Reducer implantation .

Full description

Lower Silesia Sinus Reducer Registry is a single-center, single-arm registry including all consecutive patients who were referred to the Cardiac Department of Copper Health Center due to chronic disabling refractory angina pectoris (Canadian Cardiovascular Society [CCS] classes 2-4) despite maximally tolerated anti-angina medical therapy and underwent Coronary Sinus Reducer implantation. All patients were evaluated by the local Heart Team and considered not amenable to percutaneous or surgical revascularization procedures. After the Heart Team evaluation patients were qualified for the procedure or Coronary Sinus Reducer implantation unless they met one of the exclusion criteria.

Initial patient evaluation (prior to device implantation) consisted of past medical history, actual clinical assessment with an evaluation of CCS class, Seattle Angina Questionnaire - 7 items (SAQ-7) scores, 6-min walk distance (6-MWT) test, and echocardiography. First, a follow-up visit was scheduled 1 month after the implantation procedure.The study will include clinical assessments every six months during an observation period. The primary outcomes will be gathered one year after the implantation of the CS. Nevertheless, clinical follow-up will continue for up to five years after the procedure.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. present of chronic disabling refractory angina pectoris (Canadian Cardiovascular Society [CCS] classes 2-4) despite maximally tolerated anti-angina medical therapy
  2. Heart team evaluation with consideration of ineligibility for percutaneous or surgical revascularization procedures.

Exclusion criteria

  1. recent acute coronary syndrome (<3 months),
  2. recent coronary revascularization (<3 months)
  3. a mean right atrial pressure higher than 15 mm Hg
  4. coronary sinus proximal diameter <10mm and >14mm
  5. life expectancy under 12 months,
  6. advanced heart failure (New York Heart Association [NYHA] Classification - classes 3-4),
  7. potential implantable cardiac resynchronization therapy defibrillator (CRT-D) implantation candidate.

Trial design

200 participants in 1 patient group

Coronary Sinus Reducer implantation
Description:
Subject after Coronary Sinus Reducer implantation due to chronic disabling refractory angina pectoris (Canadian Cardiovascular Society \[CCS\] classes 2-4) despite maximally tolerated anti-angina medical therapy. All patients were evaluated by the local Heart Team and considered not amenable to percutaneous or surgical revascularization procedures. After the Heart Team evaluation patients were qualified for the procedure or Coronary Sinus Reducer implantation unless they meet one of the exclusion criteria. Initial patient evaluation (prior to device implantation) consists of past medical history, actual clinical assessment with an evaluation of CCS class, Seattle Angina Questionnaire - 7 items (SAQ-7) scores, 6-min walk distance (6-MWT) test, and echocardiography. First, a follow-up visit is scheduled 1 month after the implantation procedure than the follow-up is planned twice a year.
Treatment:
Device: Coronary Sinus Reducer Implantation

Trial contacts and locations

2

Loading...

Central trial contact

Szymon Włodarczak, MD; Adrian Włodarczak, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems